Astec Lifesciences reports consolidated net loss of Rs 0.97 crore in the March 2024 quarter

Sales rise 21.09% to Rs 153.75 crore

Net Loss of Astec Lifesciences reported to Rs 0.97 crore in the quarter ended March 2024 as against net loss of Rs 4.98 crore during the previous quarter ended March 2023. Sales rose 21.09% to Rs 153.75 crore in the quarter ended March 2024 as against Rs 126.97 crore during the previous quarter ended March 2023.

For the full year,net loss reported to Rs 46.93 crore in the year ended March 2024 as against net profit of Rs 25.56 crore during the previous year ended March 2023. Sales declined 27.06% to Rs 458.18 crore in the year ended March 2024 as against Rs 628.17 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales153.75126.97 21 458.18628.17 -27 OPM %8.274.26 --1.2912.14 - PBDT8.081.58 411 -25.4968.60 PL PBT-0.93-6.18 85 -61.7534.95 PL NP-0.97-4.98 81 -46.9325.56 PL

Powered by Capital Market - Live News